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1. Introduction 
Insulin does not affect the relationship of cellular 
cyclic AMP levels to glycerol in rat adipocytes stim- 
ulated with corticotropin [l]. The inhibitory action 
of insulin on lipolysis was shown to fully account for 
the decrease in cyclic AMP. This was true, irrespective 
of whether measurements were made when cyclic 
AMP was on the upward rise after hormone stimula- 
tion, or on the decline. The curves obtained with and 
without insulin were superimposable. On the other 
hand, in the presence of ep~eph~ne, a mixed (Y- and 
&agonist, the drop in glycerol production due to insu- 
lin, has been shown to be greater than expected from 
the observed fall in cyclic AMP levels [2]. 
Phenoxybenzamine, an a-adrenergic blocker, in 
the concentration range l-l 0 PM, has been shown to 
have a potentiating effect on epinephr~e-stimulated 
lipolysis in rat fat cells [3f. We investigate here 
whether this effect of phenoxybenzamine could mod- 
ify the effects of epinephrine on lipolysis and cyclic 
AMP levels to alter their relationship sufficiently so 
that the decrease in lipolysis due to insulin can be 
fully accounted for by the observed fall in cyclic 
AMP. 
2. Materials and methods 
Most chemicals including bovine serum albumin 
(fraction V), and L~p~ep~ne were purchased from 
Sigma; D,L-isoproterenol HCl was from K and K; and 
collagenase from Worthington. Phenoxybenzamine 
HCl was a gift from Smith, Kline and French. Insulin 
Elsevier~Mo~~h-Holland Biomedical Press 
was a I O-times recrystallized preparation given by 
Novo (Copenhagen, Denmark). Cyclic [3H]AMP 
(37.7 Ci/mol) and [14C]glycerol (133 mCi/mol) were 
from New England Nuclear. 
Preparation of fat cells, determination of cell 
weight, experimental conditions and assay methods 
are as in [ 1 ,S]. In all experiments the cells were dis- 
tributed into separate polyethylene vials, gassed with 
95% 0Z/5% COZ and preincubated for 20 min with or 
without insulin. The vials were always regassed if fur- 
ther additions were made. Incubations for 10 min at 
37°C were carried out for all experiments. 
Results from representative xperiments are shown. 
Data are reported as the mean values of duplicate 
incubations. Duplicates were within 10% of each 
other in every case. All observations were confirmed 
by repetition on at least two other occasions using 
different batches of cells. The validity of expressing 
results in this manner, because of the variability in 
the degree of response from different batches of cells, 
has been discussed by others [6-81. 
3. Rest&s 
3.1. Choice of insulin concentration 
Varying concentrations of insulin have been found 
to have different effects on epinephrine-stimulated 
lipolysis and cyclic AMP levels in rat fat cells. Insulin 
had a biphasic inhibitory effect on adenylate cyclase 
in broken fat cell systems [9,10]. However, insulin, 
in the presence of norepinephrine, had a monophasic 
effect on cyclic AMP levels and a biphasic effect on 
lipolysis [8]. Experiments were therefore carried out 
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Fig.1. Effects of insulin concentration on lipotysis and cyclic 
AMP in the presence of epinephrine. Fat cells (11 mg/mI) 
were from fasted rats. 
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to determine the concentrations of insulin to be used 
for the present study. In the experiments shown in 
fig. 1, insulin at low concentrations (0.001-0.1 mu/ml) 
exerted an ant~ipolytic effect on epinephrine-stim- 
ulated lipolysis which was lost at high concentrations 
(1-l 0 mU/ml). The biphasic concentration depen- 
dence of insulin effect on lipolysis was also observed 
for the cyclic AMP content of the fat cells which 
paralleled those changes in protein kinase activity 
ratio (-cAMP/+cAMP) as shown in fig.2. 
3.2. The effects of insulin in the presence of
epinep~~~~e and i~oproterenol 
Experiments in fig.3 show that the relationship 
between epinephrine-stimulated lipolysis and cyclic 
AMP content fall on a smooth curve not observed 
when insulin was present. Insulin appeared to inhibit 
lipolysis to a greater degree than could be attributed 
to a corresponding decrease in the level of cyclic 
Fig.2. Effects of insulin concentration on cyclic AMP and 
protein kinaseactivity ratio (-cAMP/+cAMP) in the presence 
of epinephrine. Fat cells (10 mg/ml) were from fasted rats. 
AMP. These results are in agreement with those in 
[2]. Insulin, however, did not modify the relationship 
between lipolysis and cyclic AMP content when fat 
cefls were incubated with isoproterenol, which inter- 
acts predominantly with /3-adrenergic receptors. The 
results of these experiments seem to suggest hat the 
discrepency seen with insulin plus epinephrine could 
be due to an interaction of insulin with the a-mecha- 
nism of catecholamine action. If this was so, the 
observed discrepency would be corrected by the 
presence of an a-adrenergic blocker. 
3 .? . The effect of phenox_y~en~a~~i~e on insulin 
iFthi~i~‘on f epinep~~~.ne-StiFnutated lipofysis 
and cyclic AMP levels 
Phenoxybenzamine (1 and’ 10 PM) an tu-adrenergic 
Fig.3. Relationship between cyclic AMP and iipolysis in the 
presence (x) and absence (o) of insulin. Cells were from fed 
(B:50 mg/ml; D:32 mg/ml) and fasted rats (A:37 mg/ml; 
C: 35 mg/ml). Concentrations of hormones used were: 10 nM- 
1 PM epinephrine; lo-200 nM isoproterenol; I-100 ~U/ml 
insulin. 
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Fig.4. The effects of phenoxybenzamine on the relationship 
between cyclic AMP and lipolysis, activated by epinephrine, 
in the presence (x) and absence (o) of insulin. Cells from 
fasted rats (A: 23 mg/ml; B:40 mg/ml) were preincubated 
with phenoxybenzamine and insulin (O-100 pU/ml) for 
20 mm before the addition of epinephrine (0.01-L MM) and 
incubated for 10 min. 
blocker, has been shown [3] to have a potentiating 
effect on epinephrine-stimulated lipolysis in rat fat 
cells, not observed outside this concentration range. 
Experiments were therefore carried out with these 
two concentrations of phenoxybenzamine to deter- 
mine whether its potentiating effects on epinephrine- 
stimulated lipolysis could ameliorate or abolish the 
decrease in lipolysis, due to insulin, not accounted for 
by a corresponding decrease in cyclic AMP levels. 
Results of these experiments are shown in fig.4. 1 PM 
appeared to be more effective than 10 PM phenoxy- 
benzamine in modifying the effects of insulin on 
epinephrine-stimulated lipolysis and cyclic AMP con- 
tent, to sufficiently prevent their relationship from 
being altered by the presence of insulin. Subsequent 
experiments showed that under our experimental 
conditions, 1 or 2 PM were more effective than higher 
concentrations of phenoxybenzamine, and that the 
optimum concentration varied from one cell prepara- 
tion to another. Fig.5 shows 4 experiments carried 
out with 2 PM phenoxybenzamine on 4 different 
occasions. In expts. A and D, 2 PM phenoxybenzamine 
was more effective in completely preventing insulin 
from altering the relationship of cyclic AMP levels to 
lipolysis stimulated with epinephrine than in expts. 
B and C. For all these experiments, the protein kinase 
activity ratios were also determined and correlated 
with the cyclic AMP content, or glycerol release, in 
the presence and absence of insulin. The correlations 
for expt. D are shown in the right panel. Phenoxy- 
benzamine appeared to effectively prevent insulin 
from altering the relationships between any of these 
parameters in epinephrine-stimulated fat cells. 
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Fig.5. Relationship between cyclic AMP, protein kinase 
activity ratio and lipolysis activated by epinephrine and 
phenoxybenzamine, in the presence (x) and absence (0) of 
insulin. Cells from fed rats (35,34,25 and 25 mg/ml for 
A,B,C and D, respectively) were incubated under similar 
conditions as those for experiments shown in fig.4. 
4. Discussion 
Several conditions modify the effect of insulin on 
the accumulation of cyclic AMP induced by lipolytic 
hormones in adipocytes [ 11. The biphasic concentra- 
tion dependence of insulin effect could explain the 
failure of some investigators to observe a significant 
lowering of cyclic AMP levels when supraoptimal con- 
centrations were used, e.g. 0.5 mU insulin/ml [l I] 
failed to elicit any insulin effect on the elevations 
of cyclic AMP caused by epinephrine. At this concen- 
tration, insulin effects were minimal under our 
experimental conditions. 
Paradoxical effects of high concentrations of insulin 
in increasing cyclic AMP levels and lipolysis in the 
presence of 100 PM or higher epinephrine concentra- 
tions have been reported [8,12]. These effects were 
not observed in the present study as epinephrine con- 
centrations used were 1 PM or less. It was evident, 
however, that even at low epinephrine concentrations, 
insulin inhibited lipolysis by a mechanism in addition 
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to lowering cyclic AMP (fig.4). This is in agreement 
with other studies [2]. 
The experiments with isoproterenol, and the 
effects of phenoxybenzamine in modifying epineph- 
rine-induced lipolysis, suggest hat the cyclic AMP- 
dependent component of insulin inhibition might 
involve modulation of an a-adrenergic mechanism(s). 
It is well established that activation of a-receptors in 
human and hamster adipocytes reduces lipolysis 
[13,14]. The a-blocker, phenoxybenzamine, has also 
been shown to increase epinephrine-induced lipolysis 
in fat cells of hamster [ 151 and rat [2] and cr-recep- 
tors are thought to mediate the inhibition of lipolysis 
in adipose tissues [ 161. In the present study, phe- 
noxybenzamine appeared to prevent the insulin 
inhibition of lipolysis which was cyclic AMP indepen- 
dent. This is consonant with the recent report of evi- 
dence for a second pathway of lipolysis activation in 
response to epinephrine, in addition to that involving 
a cyclic AMP-mediated increase in the state of phos- 
phorylation of the hormone-sensitive lipase [ 171. 
Ca2+ have been shown to mediate a-adrenergic 
effects in the liver [ 181 and have been suggested to be 
involved in ar-responses in adipose tissue [ 191. Insulin 
effects in lowering cyclic AMP content in fat cells in 
the presence of epinephrine, however, have been 
shown not to be dependent on Ca2+ [20]. Calcium 
was also not required for insulin action on adenylate 
cyclase [ 10,211 or on phosphodiesterase [22]. Thus 
it would appear that insulin effects on the cyclic AMP 
system were independent of the a-responses. On the 
other hand, the results of the present study show that 
insulin effects on lipolysis could be due to both (Y- and 
P-responses and that low concentrations of phenoxy 
benzamine provide for an effective a-blockade. Hence 
in the presence of phenoxybenzamine, the insulin 
effects on lipolysis correlated well with its effects on 
cyclic AMP. These findings are consistent with the 
recent observation that the inhibitory action of insulin 
on corticotropin-stimulated lipolysis can be fully 
accounted for by the decrease in cyclic AMP [ 11. 
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